CCP
THC icon

Clough Capital Partners’s Tenet Healthcare THC Stock Holding History

Clough Capital Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27,090
Closed -$2.85M – 137
2024
Q1 		$2.85M Hold
27,090
– – 0.31% 62
2023
Q4 		$2.05M Sell
27,090
-5,200
-16% -$330K 0.23% 74
2023
Q3 		$2.13M Hold
32,290
– – 0.23% 94
2023
Q2 		$2.63M Sell
32,290
-122,935
-79% -$8.75M 0.26% 101
2023
Q1 		$9.22M Buy
155,225
+6,235
+4% +$347K 0.99% 33
2022
Q4 		$7.27M Buy
148,990
+31,700
+27% +$1.47M 0.74% 50
2022
Q3 		$6.05M Sell
117,290
-47,500
-29% -$2.82M 0.64% 31
2022
Q2 		$8.66M Buy
164,790
+26,290
+19% +$1.83M 1.07% 30
2022
Q1 		$11.9M Buy
138,500
+24,100
+21% +$1.98M 0.9% 44
2021
Q4 		$9.35M Buy
+114,400
New +$8.36M 0.62% 47
2013
Q4 		– Sell
-84,700
Closed -$3.49M – 231
2013
Q3 		$3.49M Sell
84,700
-108,400
-56% -$4.53M 0.11% 159
2013
Q2 		$8.9M Buy
+193,100
New +$8.65M 0.3% 112

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clough Capital Partners's THC Position: Q2 2024 in Review

Clough Capital Partners sold out of Tenet Healthcare (THC) in Q2 2024, closing a stake of 27,090 shares — an estimated $2.85M sold.

Clough Capital Partners first reported a position in THC in Q2 2013 and held it in 12 quarters. The position peaked at $11.9M in Q1 2022. 528 funds tracked by Wall St. Rank hold THC as of Q2 2024.

  • Clough Capital Partners reported no remaining Tenet Healthcare position as of Q2 2024 after selling out during the quarter.
  • Clough Capital Partners sold 27,090 Tenet Healthcare shares in Q2 2024, an estimated $2.85M.
  • Clough Capital Partners first reported a position in Tenet Healthcare in Q2 2013 and held it in 12 quarters.
  • Clough Capital Partners's Tenet Healthcare position peaked at $11.9M in Q1 2022.
  • 528 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2024.

Based on Clough Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.